PUBLISHER: The Business Research Company | PRODUCT CODE: 1641690
PUBLISHER: The Business Research Company | PRODUCT CODE: 1641690
Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.
The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.
The cannabidiol market research report is one of a series of new reports from The Business Research Company that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cannabidiol market size has grown exponentially in recent years. It will grow from $12.94 billion in 2024 to $17.85 billion in 2025 at a compound annual growth rate (CAGR) of 37.9%. The growth in the historic period can be attributed to changing regulatory environment, leading to increased legalization of cbd, growth in public awareness and acceptance of the potential health benefits of cbd, medical research supporting the use of cbd for various health conditions, emergence of diverse product categories, including cbd-infused foods, beverages, and skincare, and increased availability of cbd products through retail and e-commerce channels.
The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $58.98 billion in 2029 at a compound annual growth rate (CAGR) of 34.8%. The growth in the forecast period can be attributed to global legalization and regulatory harmonization of cbd products, pharmaceutical research and development for fda-approved cbd medications, increased consumer interest in cbd for mental health and relaxation, expansion of The pet cbd market and veterinary applications, and expansion of The hemp industry for cbd production. Major trends in the forecast period include development of novel cbd delivery methods and formulations, integration of blockchain and traceability solutions in the cbd supply chain, investment in r&d for new cbd-based pharmaceuticals, customized cbd formulations, and novel cbd delivery methods.
The growing market acceptance and utilization of CBD products, fueled by government approvals, are poised to drive the expansion of the cannabidiol market. CBD, derived from Cannabis Sativa, serves as a key ingredient in various consumer products and therapeutic applications. Recognizing the potential health benefits, governments worldwide are taking measures to improve regulatory pathways for the lawful marketing of CBD products, contributing to the market's growth. An illustrative example is the Therapeutic Goods Administration in Australia, which, in January 2022, approved approximately 210,000 SAS Category B applications for unapproved medicinal cannabis products.
The anticipated rise in neurological disorders is set to be a significant driver for the cannabidiol market. Neurological disorders affecting the central and peripheral nervous systems, including the brain and spinal cord, are increasingly prevalent. Cannabis has shown promise in treating neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As reported by the Parkinson's Foundation in December 2022, the incidence rate of Parkinson's disease in the United States surged to nearly 90,000 diagnoses annually, a notable increase from previous estimates of 60,000 yearly diagnoses.
Major companies in the cannabidiol market are concentrating on product innovation, particularly in developing non-psychotropic options that do not produce psychoactive effects. Non-psychotropic refers to substances that do not influence mental processes or alter consciousness, making them suitable for medicinal use without inducing a high. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for epilepsy treatment. This new DCGI-approved prescription cannabidiol was introduced in India to help manage seizures related to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring it is non-psychotropic. Clinical studies have shown its effectiveness in reducing seizures, especially when traditional antiseizure medications fail.
Major companies in the cannabidiol market are forming strategic partnerships to broaden their product offerings, enhance research and development capabilities, and strengthen their market presence. This approach allows them to provide essential communication services to individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in February 2024, dsm-firmenich, a Netherlands-based chemical manufacturing company, teamed up with Zerion Pharma, a Denmark-based pharmaceutical firm. Through this collaboration, they aim to develop innovative solutions that combine DSM-Firmenich's expertise in advanced materials and formulations with Zerion Pharma's strengths in pharmaceutical development.
In December 2022, Prima, a US-based health and personal care products company, acquired Prospect Farms for an undisclosed amount. This acquisition is intended to enhance its product offerings and expand its market presence. This strategic move will incorporate Prospect Farms' expertise in high-quality hemp-derived products, reinforcing Prima's commitment to wellness and sustainability. Prospect Farms is a US-based health and wellness brand that specializes in hemp-derived products.
Major companies operating in the cannabidiol market include Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Walgreens Boots Alliance, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC
North America was the largest region in the cannabidiol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cannabidiol Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cannabidiol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cannabidiol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cannabidiol market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.